SLB
56
-3
T
48
3
EQT
57
-3
GILD
56
-4
PX
73
-6
CSX
68
3
ETR
68
-3
NTAP
61
-3
CVX
38
6
MS
80
-3
CMS
58
-2
CMI
67
4
JCI
61
-2
ZTS
49
2
QRVO
4
-2
AAPL
45
3
CAH
60
2
SLG
62
-4
DIS
62
2
FRT
48
2
SLB
56
-3
T
48
3
EQT
57
-3
GILD
56
-4
PX
73
-6
CSX
68
3
ETR
68
-3
NTAP
61
-3
CVX
38
6
MS
80
-3
CMS
58
-2
CMI
67
4
JCI
61
-2
ZTS
49
2
QRVO
4
-2
AAPL
45
3
CAH
60
2
SLG
62
-4
DIS
62
2
FRT
48
2
Financhill
Back

Allogene Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
26

ALLO
Allogene Therapeutics

Last Price:
2.47
Seasonality Move:
-6.71%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
26
Allogene Therapeutics (ALLO) is a Sell

Is Allogene Therapeutics a Buy, Sell or Hold?

  • The current Allogene Therapeutics [ALLO] share price is $2.73. The Score for ALLO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ALLO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALLO Stock Price Chart

What is Allogene Therapeutics's stock price today?

  • The Allogene Therapeutics share price today is $2.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

ALLO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: -1489340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 2.99) Sell
Bollinger Bands (100): (2.42 - 2.94) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: -952055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.27 - 12.77) Sell
Bollinger Bands (100): (11.25 - 14.33) Sell

ALLO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.02 Sell
20-day SMA: 2.83 Sell
50-day SMA: 2.75 Sell
200-day SMA: 3.18 Sell
8-day EMA: 2.91 Sell
20-day EMA: 2.85 Sell
50-day EMA: 2.77 Sell
200-day EMA: 3.08 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Sell
20-day SMA: 11.83 Sell
50-day SMA: 12.88 Sell
200-day SMA: 12.8 Sell
8-day EMA: 11.13 Sell
20-day EMA: 11.74 Sell
50-day EMA: 12.46 Sell
200-day EMA: 11.73 Sell

Allogene Therapeutics Earnings Growth & ALLO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and a decrease next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.

Allogene Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):